Vivian Mo, MD

Clinical Professor of Medicine (Clinician Educator)

Interim Chief of the Division of Cardiology

Image of Vivian Mo, MD
Is this your profile? Click to edit


Dr. Vivian Mo is a Clinical Associate Professor of Medicine and specializes in cardiology and echocardiography. She completed her internship and residency in internal medicine and a fellowship in cardiology at the University of Texas – Southwestern Medical Center in Dallas, Texas. She is an active medical educator in the cardiovascular medicine fellowship program and, while at USC, has investigated characteristics of right ventricle function in pulmonary hypertension and published on echocardiographic measures in the setting of pericardial effusion and cardiac tamponade. Clinically, she supports a growing structural heart disease program through interventional echocardiography for procedures in transcatheter aortic valve replacement, MitraClip, atrial and ventricular defect closure, Watchman device implants, etc. From a physician leader perspective, she is the Chief Medical Officer of USC Care Medical Group and has worked to improve the quality of healthcare delivered in-hospital and in the ambulatory setting on required and independent metrics. She has a keen focus on streamlining operational processes for efficiency and optimizing patient care, and aligning physician work efforts and engagement within USC’s clinical programs.

Dr. Mo is a Fellow of the American College of Cardiology and American Society of Echocardiography.


  • Charles S. Houston Award, 2007
  • University of Texas- Southwestern Medical Center: Nomination for Outstanding Clinical Medicine Resident, 2003
  • Psi Chi Honor Society: Excellence in Psychology, 1996
  • Houston International Fund: Scholarship, 1996
  • LEXIA Scholarship, 1995


  • B-type natriuretic peptide, vascular endothelial growth factor, endothelin-1, and nitric oxide synthase in chronic mountain sickness Am J Physiol Heart Circ Physiol. 2011 Apr; 300(4):H1427-33. . View in PubMed
  • High-sodium food choices by southern, urban African Americans with heart failure J Card Fail. 2006 Mar; 12(2):144-8. . View in PubMed
  • The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease Future Cardiol. 2005 Sep; 1(5):649-56. . View in PubMed
  • Individualizing therapy in acute coronary syndromes: using a multiple biomarker approach for diagnosis, risk stratification, and guidance of therapy Curr Cardiol Rep. 2004 Jul; 6(4):273-8. . View in PubMed
  • Disparity in pathologic and clinical lymph node staging in oral tongue carcinomaImplication for therapeutic decision making. Cancer. 2003 Aug 01; 98(3):508-15. . View in PubMed
  • Extent of extracapsular spread: a critical prognosticator in oral tongue cancer Cancer. 2003 Mar 15; 97(6):1464-70. . View in PubMed
  • Extracapsular spreadA significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001 Dec 15; 92(12):3030-6. . View in PubMed